Danny Jones

That would be a red flag.

Not a single FOIA request.

And so here's another example, the GLP-1 weight loss drugs.

They grew so fast that the big pharmaceutical companies couldn't keep up with the demand of the American people.

And these drugs were originally indicated as a diabetic medication, meant to be helping poverty-stricken communities, people with severe diabetes.

But when every housewife in Malibu's taking it to lose 10 pounds for spring break, you couldn't get it anymore.

So then the prices just kept going up.

At one point, the average retail price of a GLP-1 drug in North America was $1,300 a month.

Whoa.

$1,300 a month for a medication that we could compound and mail to your doorstep for under $200.

The federal government released guidelines saying this is now put on an emergency backlog list.

Can compounders please make this drug?

We can't meet the need of the American people.

Diabetics are not able to get their medication because so many Americans are taking this weight loss drug.

So we go out and we start compounding those drugs because we were asked to by the FDA.

What happens?

Within months, even though we were asked to come on this drug, Eli Lilly sues us.

Now you have to litigate against Eli Lilly in the court system.

And Eli Lilly says, and they lobby the FDA.

You can't let these guys make this.